Journey through 30 years of AIDS: African leadership in HIV response
Voyage à travers 30 ans de SIDA: Le Leadership Africain dans la Réponse au VIH
Meskerem Grunitzky Bekele, Togo
Dr. Meskerem Grunitzky Bekele is Director of the UNAIDS Regional Support Team for West and Central Africa based in Dakar, Senegal, covering 25 countries in West and Central Africa (WCA). Prior to joining UNAIDS, she held a number of academic positions in Togo including Head of the Department of Infectious Disease at CHU Tokoin Teaching Hospital and Lecturer at the Faculty of Medicine at the University of Lome. She also served as Director of Togo's National AIDS and STDs Program. She joined UNAIDS in 1996 as team leader of the UNAIDS Inter-country Team for West and Central Africa and was responsible for establishing UNAIDS first regional presence in Africa. From 2000 to 2004, she was Associate Director of the Africa Division, responsible for the coordination of UNAIDS support to African countries in their response to HIV and manager of the UNAIDS-coordinated International Partnership against AIDS in Africa. Throughout her career and for the past thirty years, Dr. Grunitzky Bekele’s work focus was to build partnerships, mobilize African leaders from diverse sectors, at the highest level around HIV and AIDS. Furthermore, she has been a driving force in promoting the work of the Civil Society, in particular, People Living with HIV (PLHIV) as well as other African Regional institutions, such as the African Union, Regional Economic Commissions (RECs), First Ladies’ Organizations, the Society for AIDS in Africa (SAA), and many more. Born and raised in Ethiopia, Dr. Grunitzky Bekele completed her medical studies at the Université d'Aix Marseille in France and specialized in Tropical Diseases. She is also a memeber of the Société de Pathologie Infectieuse de Langue Française.
Owning and sustainig HIV response in Africa: Community perspectives and contrubutions
S’Approprier et Maintenir la Réponse au VIH en Afrique : Perspectives et Contributions de la Communauté
Cheick Tidane Tall, Mali
Dr. Cheick Tidiane Tall is the Executive Director of the African Council on AIDS Service Organizations (AfriCASO). This is a regional network that promotes and facilitates the development of HIV and AIDS community responses in Africa, through advocacy, networking, development of sustainable organizational systems and capacity building for networks and NGOs.. He is an accomplished medical doctor in the international development domain, with 19 years’ professional experience in private clinic management, health and health systems issues, sexual and reproductive health, HIV and AIDS. He has extensive knowledge of community organizations working on health in Africa and around the world. His portfolio extends to experience in proposal development and implementation, advocacy and resource mobilization. He is widely versed on the HIV and AIDS epidemic and STIs: scientific aspects, trends of evolution, policies, challenges and priorities and formulation of national responses. He is a Board Member for the developing country-NGO delegation to the Global Fund Board.
Accountability through ownership, shared responsibilities and financial sustainability
La Responsabilisation à travers l’Appropriation, les Responsabilités Partagées et la Durabilité Financière
John Idoko, Nigeria
John Idoko is the Director of the AIDS Prevention Initiative in Nigeria (APIN), a program at the University of Jos in Nigeria. He is also the Chairman of the Nigerian Antiretroviral Committee. A Professor of Infectious Disease at the University of Jos, he previously led the Jos University Teaching Hospital efforts in their PEPFAR supported care and treatment of over 13,000 patients; one of the largest ART clinics in Africa. . He has undertaken extensive clinical and research work in HIV and AIDS and published several papers on the management of AIDS in Nigeria. Professor Idoko has served as the Director General of the National Agency for the Control of AIDS (NACA) since early 2009; he comes to this position with decades of experience in HIV prevention, treatment and care. A leading expert in ART for the country, he has also developed and implemented a successful roll-out of PMTCT services to all local governments in Plateau State.
Thirty years response to HIV and AIDS: Situation and response trends in Africa
Trente ans de réponse au VIH et au SIDA : Situation et tendance de réponse en Afrique
Peter Piot, Belgium
Peter Piot, MD, PhD (born 1949) a former Under Secretary-General of the United Nations, former Executive Director of the UN specialized agency UNAIDS, and a former professor at Imperial College London, is now Director of the London School of Tropical Medicine & Hygiene. After he qualified as a Doctor of Medicine at the University of Ghent (Belgium) in 1974, he co-discovered the Ebola virus in Zaire in 1976. In 1980, Peter Piot received a PhD degree in Microbiology from the University of Antwerp (Belgium). He was also a Senior Fellow at the University of Washington in Seattle. In the 1980s, Dr. Piot participated in a series of collaborative projects on AIDS in Burundi, Côte d'Ivoire, Kenya, Tanzania and Zaire. Project SIDA in Kinshasa, Zaire was the first international project on AIDS in Africa and is widely acknowledged as having provided the foundations of our understanding of HIV infection in Africa. He was a professor of microbiology, and of public health at the Institute of Tropical Medicine in Antwerp, and the Universities of Nairobi, Brussels, and Lausanne. From 1991 to 1994, Dr. Piot was President of the International AIDS Society. In 1992, he became Associate Director of the World Health Organization’s Global Programme on HIV/AIDS. On 12 December 1994, he was appointed Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS). He stepped down from this role in late 2008, at which time he was replaced by Michel Sidibé from Mali. He was a Senior Fellow at the Bill and Melinda Gates Foundation, a Scholar in Residence at the Ford Foundation, and held a Chair at the College de France in Paris in 2009-10. Dr. Piot was ennobled a Baron by King Albert II of Belgium in 1995, and has received numerous awards. He is a member of the Institute of Medicine of the National Academy of Sciences of the United States, of the Academy of Medical Sciences of the UK, and the Academies of Medicine in Belgium and France. He is fluent in three languages and is the author of 16 books and more than 500 scientific articles
Health systems strengthening in Africa: Innoviative technologies for HIV response in Africa
Renforcement des systèmes de santé en Afrique : Technologies innovantes dans la réponse au VIH en Afrique
John Nkengasong, Côte d'Ivoire
John Nkengasong, PhD. is the Associate Director for Laboratory Science in the CDC’s Division of Global HIV/AIDS (DGHA). He also serves as the Chief of the division’s International Laboratory Branch and is co-chair of the U.S. President's Emergency Plan for AIDS Relief’s (PEPFAR) Laboratory Technical Working Group. Dr. Nkengasong recently spearheaded the creation of the African Society of Laboratory Medicine, where he is Chair of the Board of Directors. Dr. Nkengasong joined CDC in 1995 as Chief of the Virology Laboratory, CDC Abidjan, Cote d’Ivoire. In 2005, he joined DGHA as Chief of the International Laboratory Branch. His extensive work on HIV diagnosis, pathogenesis, and HIV Drug resistance has been consistently published since 1988, spanning over 120 papers in journals such as the Lancet, Journal of Virology, Journal of Infectious Diseases, and Journal of Clinical Microbiology. His portfolio includes multiple published book chapters on implementation of HIV therapy in resource-challenged areas. He has received a number of awards including the U.S. Secretary of Health and Human Services Award for Excellence in Public Health Protection Research and multiple Directors’ Recognition Awards. He has been nominated several times for the Agency’s prestigious Shepard Award. He continues to serve on numerous international advisory boards and journal review panels. Dr. Nkengasong received a Master of Tropical Biomedical Science at the Institute of Tropical Medicine in Antwerp, Belgium, in addition to a Masters Degree in Medical and Pharmaceutical Sciences and a Doctorate in Medical Sciences (Virology) from the University of Brussels School of Medicine, Belgium. From 1993-1995, he served as the Chief of the Virology Laboratory at the Department of Microbiology, Institute of Tropical Medicine, a World Health Organization Collaborating Center on HIV diagnostics.
Where is Africa in PMTCT: Successes, challenges, and MTCT elimination
Où est l’Afrique en matière de PTME ?: Succès, défis et élimination de la TME
Chewe Luo, Zambia
Dr. Chewe Luo is a Pediatrician and Tropical Child Health Specialist. She is currently working as Technical Team Leader for Country Program Scale-up and Senior Program Adviser for HIV at the United Nations Children’s Fund (UNICEF) in New York. She has over 15 years of experience in HIV and AIDS and child health as a clinician and researcher at the University Teaching Hospital in Zambia; clinician in the UK and working with UNICEF at country, regional and headquarter levels. She has a Masters of Medicine in Paediatrics from the University of Zambia and Masters in Tropical Pediatrics and a PhD from Liverpool School of Tropical Medicine in the UK.
Combination prevention approach in the response to HIV and STIs
Approche de combinaison préventive dans la réponse au VIH et aux IST
Sheila Tlou, Botswana
Dr. Sheila D. Tlou is Director of the UNAIDS Regional Support Team for Eastern and Southern Africa. She is a former Member of Parliament and Minister of Health of the Republic of Botswana (2004-2009). She has been involved in the fight against HIV and AIDS from the time the epidemic started in Botswana in 1985, and is the founder President of the Botswana chapter of the Society of Women and AIDS in Africa (SWAA).
Dr. Tlou holds a PhD in Nursing Sciences and postgraduate Certificates in Women’s health and Gender studies, from the University of Illinois at Chicago. During her term as Minister of Health, Dr. Tlou led a comprehensive AIDS response program whose achievements include a roll out of ARVs to near universal (96%) uptake. Transmission of HIV from mother to child decreased from 40% in 2003 to about 4% in 2008, and maternal mortality due to AIDS decreased from 38% to 9%. As Chairperson of the African Union Ministers of Health in 2005, Dr. Tlou provided leadership in the adoption of the Maputo Plan of Action on Sexual and Reproductive Health and Rights. Dr Tlou also represented Eastern and Southern Africa in the Board of the Global Fund for AIDS, Tuberculosis and Malaria.
Among the award she has received include the 2002 Botswana Presidential Order of Honour, the 2002 Anna Reynvaan Award from the Amsterdam Medical Centre, the 2003 Florence Nightingale Award from the International Red Cross Society, and the 2007 Trailblazer Woman Leading Change Award from the World YWCA. She has portrayed Precious Ramotswe, the heroine of Alexander McCall Smith’s Number One Ladies Detective Agency book series, in several amateur theatre productions in Botswana, and starred in the Anthony Mingella BBC Movie: The Number One Ladies Detective Agency (2008).
AIDS and the Millennium Development Goal: Working together for greater impact
Le SIDA et les Objectifs de Développement du Millénaire : Travailler ensemble pour avoir un plus grand impact
Stephen Lewis, Canada
Mr. Stephen Lewis is the co-founder and co-director of AIDS-Free World (www.aidsfreeworld.org), an international advocacy organization that works to promote more urgent and more effective global responses to HIV and AIDS. Stephen Lewis’ work with the United Nations spanned more than two decades. He was the UN Secretary-General’s Special Envoy for HIV/AIDS in Africa from 2001 until 2006. From 1995 to 1999, Mr. Lewis was Deputy Executive Director of UNICEF in New York. From 1984 through 1988, he was Canada's Ambassador to the United Nations. In addition to his work with AIDS-Free World, Mr. Lewis is a Distinguished Visiting Professor at Ryerson University in Toronto. He also serves as a Commissioner on the newly formed Global Commission on HIV and the Law, created by the United Nations Development Programme (UNDP) with the support of the Joint United Nations Programme on HIV/AIDS (UNAIDS). Mr. Lewis serves as the Board Chair of the Stephen Lewis Foundation, in Canada. He is a member of the Board of Directors of the Clinton Health Access Initiative and Emeritus Board Member of the International AIDS Vaccine Initiative.
Mr. Lewis holds 34 honorary degrees from Canadian universities and in June 2010 he received an honorary degree from Dartmouth College. He was appointed a Companion of the Order of Canada, Canada’s highest honour for lifetime achievement, in 2003. In 2007, King Letsie III, monarch of the Kingdom of Lesotho (a small mountainous country in Southern Africa) invested Mr. Lewis as Knight Commander of the Most Dignified Order of Moshoeshoe. Named after the founder of Lesotho, the knighthood is the country’s highest honour.
Advances in addressing HIV vulnerability: Women, children and youth and the gender perspective
Avancées dans la manière de gérer la vulnérabilité face au VIH : Femmes, enfants, jeunes et la perspective du genre
Annah Sango, Zimbabwe
Annah Sango is a peer educator and role model to other young women in Bulawayo, Zimbabwe. She is a member of the International Community of Women Living with HIV and AIDS (Southern Africa) and founded her own community-based support group for women affected by HIV. Annah is also a trainer of trainers on issues facing young people and has a certificate in basic counseling. She is a tireless advocate for the reproductive and sexual health rights of young women living with HIV throughout her region, including ensuring their access to woman-initiated prevention options like female condoms.
Co-Author for published paper: Nduku Kilonzo, Kenya
Treatment as prevention to HIV: Concepts and prospects
Traiter pour prévenir le VIH: Concepts et possibilités
David Serwadda, Uganda
David Serwadda is a Ugandan physician, medical researcher, academic, public health specialist and medical administrator. Currently, he is a professor of public health at Makerere University School of Public Health (MUSPH). He is also a founding member of Accordia Global Health Foundation’s Academic Alliance. In the early 1980s, he was one of the earliest physicians in Uganda to recognize HIV and AIDS. He has been a leading researcher in the epidemiology of HIV and AIDS in Sub-Saharan Africa. He has published the findings of his research in numerous medical journals and other peer publications. In 2003, he was appointed Director of the then Makerere Institute of Public Health. He served in that position until 2007 when he was promoted to the position of Dean, MUSPH, following the elevation of the Institute to a constituent School of Makerere University College of Health Sciences (MUCHS). He later step down as Dean of the School of Public Health, but continues to teach and carry out research in his capacity as Professor of Public Health. In Uganda he leads the Rakai Health Science Program, which has significantly contributed to our undertaking of the dynamics of HIV transmission in rural populations in Africa. His expertise has also been sought by the World Health Organization (WHO) in their Department of Reproductive Health and Research and the International Scientific Committee on research pertaining to AIDS and Associated Cancers in Africa.
Challenges and prospects for antiretroviral therapy in Africa: Access and sustainability
Défis et Perspectives des Traitements Antirétroviraux en Afrique : Accès et Durabilité
Phyllis Kanki, USA
Phyllis Kanki has been a professor of Immunology and Infectious Disease at the Harvard School of Public Health since 1999. A virologist with recognized expertise in the pathogenesis and molecular epidemiology of HIV in Africa, she has led AIDS research programs in Senegal for over 25 years. Collaborative studies with the University Cheikh Anta Diop, focused on the identification and reduced transmission of HIV-2, cross protection between HIV-2 and HIV-1, and the various times to disease development for different HIV-1 genotypes. Since 2000, Professor Kanki directed the AIDS Prevention Initiative in Nigeria (APIN), a program funded by the Bill and Melinda Gates Foundation to develop evidenced-based prevention interventions with university partners in Nigeria. In 2004, the President’s Emergency Plan for AIDS Relief (PEPFAR) funded the Harvard PEPFAR project, “Rapid Expansion of Antiretroviral Therapy Program”. She is the principal investigator of the Harvard program, which provides training, capacity building and targeted evaluation in Botswana, Nigeria and Tanzania while currently supporting access to antiretroviral therapy (ART) for over 155,000 patients.
Right issues in sexual reproduction health and HIV/STIs among the youth
La question des droits de santé reproductive et sexuelle, le VIH et les IST auprès de la jeunesse
Tewodros Melesse, Ethiopia
Mr. Tewodros Melesse was appointed Director-General of IPPF in September 2011. Having worked since 2002 as IPPF Africa Regional Director, he brings more than 27 years of experience with organizations committed to sexual and reproductive health and rights for all. IPPF is the world’s largest non-governmental organization working in this field. With a Strategic Framework adopted by over 150 Member Associations it addresses five key areas: Adolescents, HIV and AIDS, Abortion, Access and Advocacy. Mr Melesse is a passionate advocate and is committed to working in strong partnership to achieve change with governments, donors and not-for-profit organizations. His leadership assisted with the development and adoption of the Africa Union Maputo Plan of Action which he believes will save the lives of future women and girls and provides the necessary policy framework to increase universal access to comprehensive sexual and reproductive health in Africa. Prior to IPPF, Mr. Melesse held the position of Country Representative (Ethiopia) for Pathfinder International. He has a degree in Economics (Catholic University, Louvain, Belgium). A citizen of Ethiopia and a permanent resident of Australia, he is based in the United Kingdom. He is fluent in English and French. Mr. Melesse is married with two adult daughters.
Tretment 2.0: New approaches in HIV treatment and prevention
Traitement 2.0 : Nouvelles Approches dans le traitement du VIH et la prévention
Marco Vitoria, Brazil
Dr. Marco Vitoria is an HIV expert at the World Health Organization based in Geneva, Switzerland. He is a senior staff in the WHO Headquarters in charge of care and treatment programs. He has been behind the development and updates of the global guidelines in treatment and care that has been implemented in countries since 2003. Dr. Vitoria has an extensive experience in HIV clinical and program management and previously worked on antiretroviral treatment scale-up in Brazil for the Brazilian National AIDS Program, a pioneer governmental program on HIV and AIDS.
HIV and social justice: Addressing policy and structural barriers to effective HIV responses for key populations (people in closed settings; LGBTI people; sex workers, and people who use drugs
Le VIH et la Justice Sociale : Aborder les barrières politiques et structurelles empêchant une réponse efficace au VIH pour les populations-clés (personnes en milieux clos, personnes de la communauté LGBTI, travailleurs sexuels, toxicomanes))
Marlise Richter, South Africa
Marlise has a BA (Hons) and LLM degree from Wits University (South Africa) and an MA in International Peace Studies from the University of Notre Dame (USA). She has worked as a researcher for the AIDS Law Project, Treatment Action Campaign and the Reproductive Health and HIV Research Unit. Her research interests lie in feminism and HIV and AIDS with a particular focus on sex work and sexual and reproductive health. Marlise has been an active researcher and advocate on the decriminalization of sex work and the realization of human rights for marginalized groups within the AIDS epidemic. Her work has included collaboration with the African Sex Worker Alliance, the AIDS and Rights Alliance for Southern Africa, and the South African National AIDS Council. Marlise is currently working towards her PhD at the International Centre for Reproductive Health at the University of Ghent (Belgium) and is a visiting researcher at the African Centre for Migration & Society Wits University.
Achiving universal access to HIV treatment for TB patients: Science and politics
Atteindre l’accès universel au traitement pour le VIH et la Tuberculose : Science et politique
Diane V. Havlir, USA
Diane V. Havlir is a professor of Medicine and Chief of the HIV/AIDS Division at San Francisco General Hospital and the University of California, San Francisco (UCSF). She has worked as a researcher and clinician in the HIV epidemic for over 20 years. After earning her MD degree at Duke University Medical School in 1984, she began her medical career as an intern and resident in internal medicine at UCSF. Dr. Havlir spearheaded early studies of opportunistic infection treatment and prophylaxis and conducted pivotal studies on nevirapine viral dynamics, antiretroviral therapeutic strategies, and HIV drug resistance. At UCSF, she is Chief of the AIDS Division and Director of the HIV Translational Research Training Program. She has won numerous mentorship awards for her commitment to training young scientists. She also currently directs several antiretroviral trials evaluating novel strategies for the treatment of HIV and co-infections (tuberculosis and malaria). She leads research studies with Dr. Kamya in Uganda through the Makerere University-UCSF Collaboration. Dr. Havlir’s research accomplishments were recognized with the HIV Research Achievement Award of the Infectious Diseases Society of America and HIV Medicine Association. Dr. Havlir was elected to the American Society for Clinical Investigation and is a member of the World Health Organization (WHO) HIV Treatment Guidelines Committee and a founding member of the WHO International HIV Drug Surveillance Program. She served on the Governing Council of the International AIDS Society. In 2006, she was elected to Chair the TB/HIV Working Group of the WHO Stop TB Partnership. She was also the Scientific Co-Chair for the Vienna 18th International AIDS Conference - AIDS 2010. Dr. Havlir is the Co-Chair of upcoming International AIDS Conference in Washington, DC in 2012 - “Turning the tide together.”
Finincing HIV and AIDS programs in Africa: Hopes and challenges
Financer les programmes sur le VIH et le SIDA en Afrique : Espoirs et Défis
Debrework Zewdie, Ethiopia
Dr. Debrework Zewdie, an Ethiopian national, has dedicated the past 28 years to mitigating the impact of the AIDS epidemic in her diverse capacities as scientist, strategist, manager, policy maker, program implementer, advocate and activist. Dr. Zewdie’s 28 years of work experience include managing programs of varying size and complexity ranging from national AIDS programs and international NGOs to international organizations. Before joining the Global Fund, she held different leadership positions at the World Bank for 15 years, most recently as Director of the Global HIV/AIDS Program. Dr. Zewdie received her PhD in Clinical Immunology from the University of London and was a Senior MacArthur Fellow at Harvard University. She has numerous publications in her area of expertise.